Kenvue to Showcase New Clinical Data on Skin Longevity, Hydration and Sun Protection at American Academy of Dermatology Association Meeting
Kenvue Inc. (NYSE: KVUE) had its price target raised by analysts at Canaccord Genuity Group Inc. from $24.00 to $29.00. They now have a "buy" rating on the stock.
Kenvue Announces Three New Appointments to Board of Directors [Yahoo! Finance]
Kenvue Announces Three New Appointments to Board of Directors
Kenvue Inc. (NYSE: KVUE) had its price target raised by analysts at Piper Sandler from $24.00 to $27.00. They now have an "overweight" rating on the stock.